These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 2997342
1. [Comparative study on sultamicillin and bacampicillin in the treatment of respiratory tract infections]. Kobayashi H, Takamura K, Kono K, Nihei T, Saito A, Nakayama I, Ujiie A, Yajima O, Tango M, Tomizawa M. Kansenshogaku Zasshi; 1985 Jul; 59(7):708-48. PubMed ID: 2997342 [No Abstract] [Full Text] [Related]
2. Sultamicillin experiences in the field of internal medicine. Hara K, Kobayashi H. APMIS Suppl; 1989 Jul; 5():51-6. PubMed ID: 2660872 [Abstract] [Full Text] [Related]
3. Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae. Pressler T, Pedersen SS, Christiansen L, Szaff M, Koch C, Høiby N. J Antimicrob Chemother; 1986 Apr; 17(4):529-33. PubMed ID: 3011725 [Abstract] [Full Text] [Related]
12. Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis. Jones S, Yu VL, Johnson JT, Wagner RL, Kim HK. Antimicrob Agents Chemother; 1985 Dec; 28(6):832-3. PubMed ID: 3002247 [Abstract] [Full Text] [Related]
13. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease. Galante D, Esposito S, Barba D, Ruffilli MP. J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850 [Abstract] [Full Text] [Related]
14. Two regimens of sultamicillin in treating uncomplicated gonorrhoea. Farthing C, Thin RN, Smith S, Phillips I. Genitourin Med; 1985 Feb; 61(1):44-7. PubMed ID: 3002961 [Abstract] [Full Text] [Related]
16. Tolerance of two ampicillin esters: a comparison of pivampicillin and bacampicillin. Hjort N, Renmarker K, Rosberg B, Skog PA, Hey H. Pharmatherapeutica; 1983 Feb; 3(6):398-404. PubMed ID: 6353431 [Abstract] [Full Text] [Related]
17. [Comparative study of the effectiveness of lenampicillin and bacampicillin on bacterial pneumonia by double blind method]. Miki F, Ikuno Y, Inoue E, Yosiyama M, Murata T, Tanizawa S, Sakamoto K, Sakai H, Saito A, Tomizawa M. Kansenshogaku Zasshi; 1985 Jun; 59(6):605-38. PubMed ID: 3932547 [No Abstract] [Full Text] [Related]
18. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors]. Tamura M, Ito T. Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135 [No Abstract] [Full Text] [Related]
19. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms. Syriopoulou V, Bitsi M, Theodoridis C, Saroglou I, Krikos X, Tzanetou K. Rev Infect Dis; 1986 Mar; 8 Suppl 5():S630-3. PubMed ID: 3026016 [Abstract] [Full Text] [Related]
20. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children. Ginsburg CM, McCracken GH, Olsen K, Petruska M. J Antimicrob Chemother; 1985 Mar; 15(3):345-51. PubMed ID: 2987174 [Abstract] [Full Text] [Related] Page: [Next] [New Search]